0000310158
country:US
us-gaap:OperatingSegmentsMember
mrk:DificidMember
mrk:PharmaceuticalsegmentMember
2025-01-01
2025-03-31
0000310158
us-gaap:NonUsMember
us-gaap:OperatingSegmentsMember
mrk:DificidMember
mrk:PharmaceuticalsegmentMember
2025-01-01
2025-03-31
0000310158
us-gaap:OperatingSegmentsMember
mrk:DificidMember
mrk:PharmaceuticalsegmentMember
2025-01-01
2025-03-31
0000310158
country:US
us-gaap:OperatingSegmentsMember
mrk:DificidMember
mrk:PharmaceuticalsegmentMember
2024-01-01
2024-03-31
0000310158
us-gaap:NonUsMember
us-gaap:OperatingSegmentsMember
mrk:DificidMember
mrk:PharmaceuticalsegmentMember
2024-01-01
2024-03-31
0000310158
us-gaap:OperatingSegmentsMember
mrk:DificidMember
mrk:PharmaceuticalsegmentMember
2024-01-01
2024-03-31
0000310158
country:US
us-gaap:OperatingSegmentsMember
mrk:ZerbaxaMember
mrk:PharmaceuticalsegmentMember
2025-01-01
2025-03-31
0000310158
us-gaap:NonUsMember
us-gaap:OperatingSegmentsMember
mrk:ZerbaxaMember
mrk:PharmaceuticalsegmentMember
2025-01-01
2025-03-31
0000310158
us-gaap:OperatingSegmentsMember
mrk:ZerbaxaMember
mrk:PharmaceuticalsegmentMember
2025-01-01
2025-03-31
0000310158
country:US
us-gaap:OperatingSegmentsMember
mrk:ZerbaxaMember
mrk:PharmaceuticalsegmentMember
2024-01-01
2024-03-31
0000310158
us-gaap:NonUsMember
us-gaap:OperatingSegmentsMember
mrk:ZerbaxaMember
mrk:PharmaceuticalsegmentMember
2024-01-01
2024-03-31
0000310158
us-gaap:OperatingSegmentsMember
mrk:ZerbaxaMember
mrk:PharmaceuticalsegmentMember
2024-01-01
2024-03-31
0000310158
country:US
us-gaap:OperatingSegmentsMember
mrk:WinrevairMember
mrk:PharmaceuticalsegmentMember
2025-01-01
2025-03-31
0000310158
us-gaap:NonUsMember
us-gaap:OperatingSegmentsMember
mrk:WinrevairMember
mrk:PharmaceuticalsegmentMember
2025-01-01
2025-03-31
0000310158
us-gaap:OperatingSegmentsMember
mrk:WinrevairMember
mrk:PharmaceuticalsegmentMember
2025-01-01
2025-03-31
0000310158
country:US
us-gaap:OperatingSegmentsMember
mrk:WinrevairMember
mrk:PharmaceuticalsegmentMember
2024-01-01
2024-03-31
0000310158
us-gaap:NonUsMember
us-gaap:OperatingSegmentsMember
mrk:WinrevairMember
mrk:PharmaceuticalsegmentMember
2024-01-01
2024-03-31
0000310158
us-gaap:OperatingSegmentsMember
mrk:WinrevairMember
mrk:PharmaceuticalsegmentMember
2024-01-01
2024-03-31
0000310158
country:US
us-gaap:OperatingSegmentsMember
mrk:AllianceRevenueAdempasVerquvoMember
mrk:PharmaceuticalsegmentMember
2025-01-01
2025-03-31
0000310158
us-gaap:NonUsMember
us-gaap:OperatingSegmentsMember
mrk:AllianceRevenueAdempasVerquvoMember
mrk:PharmaceuticalsegmentMember
2025-01-01
2025-03-31
0000310158
us-gaap:OperatingSegmentsMember
mrk:AllianceRevenueAdempasVerquvoMember
mrk:PharmaceuticalsegmentMember
2025-01-01
2025-03-31
0000310158
country:US
us-gaap:OperatingSegmentsMember
mrk:AllianceRevenueAdempasVerquvoMember
mrk:PharmaceuticalsegmentMember
2024-01-01
2024-03-31
0000310158
us-gaap:NonUsMember
us-gaap:OperatingSegmentsMember
mrk:AllianceRevenueAdempasVerquvoMember
mrk:PharmaceuticalsegmentMember